3 reports

• The global market for cancer stem cells will grow from $745 million in 2017 to $1.9 billion by 2022 with a compound annual growth rate (CAGR) of 21.2% for the period of 2017-2022. • Leukemia stem cells market will grow from $240 million in 2017 to $606 million by 2022 with a CAGR of 20.4% for the period of 2017-2022. • Breast cancer...

• The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022. • Lung cancer as a segment is expected to grow from $15.7 billion in 2017 to $22.6 billion in 2022 at a CAGR of 7.6% for the period 2017-2022. • Stomach cancer as a...

• The Chinese cancer intervention market reached nearly $41.1 billion in 2016. This market should reach $46.7 billion in 2017 and $89.3 billion by 2022, at a compound annual growth rate (CAGR) of 13.8% through 2022. • Cancer treatment services as a segment should reach nearly $43.9 billion in 2017 and $83.6 billion by 2022, at a CAGR of...